| Financial Year |
March 31 2023 |
| Monetary Funds |
939,477,711.71 |
| Held-for-trading Financial Assets |
144,003,401.84 |
| Notes Receivable |
35,786,904.05 |
| Accounts Receivable |
180,728,655.32 |
| Advances to Suppliers |
13,917,076.35 |
| Other Receivables |
3,837,474.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,120,387.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,701,743.54 |
| Total Current Assets |
1,591,464,943.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
67,768,887.48 |
| Under-construction Projects |
37,363,284.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,115,865.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,167,770.61 |
| Deferred Income Tax Assets |
14,079,388.93 |
| Other Non-Current Assets |
373,879.71 |
| Sub-Total of Non-Current Assets |
218,471,932.37 |
| Total Assets |
1,809,936,875.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
85,005,219.93 |
| Accounts Payable |
126,664,501.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,674,097.85 |
| Taxes Payable |
8,940,168.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,634,415.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,091,811.20 |
| Other Current Liabilities |
11,124,240.40 |
| Sub-Total of Current Liabilities |
346,028,715.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,395,034.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,785,813.86 |
| Total Liabilities |
385,814,529.22 |
| Paid-In Capital(Or Share Stock) |
111,430,768.00 |
| Capital Surplus |
704,887,462.87 |
| Surplus Reserve |
126,619,568.75 |
| LESS:Treasury Stock |
23,985,449.60 |
| Undistributed Profits |
504,818,407.82 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,424,122,346.29 |
| Owner's Equity（Stockholder's Equity） |
1,424,122,346.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,809,936,875.51 |
